Publications and communications of Philippe Martinive

Donis, N., Jiang, Z., D'Emal, C., Hulin, A., Debuisson, M., Dulgheru, R. E., Nguyen, M.-L., Postolache, A., LALLEMAND, F., COUCKE, P., Martinive, P., Herzog, M., Pamart, D., Terrell, J., Pincemail, J., Drion, P., DELVENNE, P., Nchimi Longang, A., LANCELLOTTI, P., & Oury, C. (28 February 2022). Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve. Frontiers in Cardiovascular Medicine, 9, 1-16. doi:10.3389/fcvm.2022.839720

LALLEMAND, F., LEROI, N., Blacher, S., Bahri, M. A., Balteau, E., COUCKE, P., Noël, A., Plenevaux, A., & Martinive, P. (2021). Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study. Frontiers in Oncology. doi:10.3389/fonc.2021.784437

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2019). Tumor modifications recorded with IVIM and DCE-MRI after Neoadjuvant radiotherapy. Radiotherapy and Oncology, 133 (Supplement 1), 284 - S285. doi:10.1016/S0167-8140(19)30960-0

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Tumor microenvironment modifications recorded with IVIM perfusion analysis after radiotherapy. Radiotherapy and Oncology, 127 (Supplement 1), 1285-S1286. doi:10.1016/S0167-8140(18)32640-9

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Brain modifications after stereotactic radiotherapy recorded by Functional MRI. Radiotherapy and Oncology, 127 (Supplement 1), 582. doi:10.1016/S0167-8140(18)31346-X

Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., LALLEMAND, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (2018). Correction to: A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes (Nature Immunology, (2017), 18, 12, (1310-1320), 10.1038/ni.3857). Nature Immunology, 19 (9), 1035. doi:10.1038/s41590-017-0024-8

Vandaele, R., Aceto, J., Muller, M., Peronnet, F., Debat, V., Wang, C.-W., Huang, C.-T., Jodogne, S., Martinive, P., Geurts, P., & Marée, R. (2018). Landmark detection in 2D bioimages for geometric morphometrics: a multi-resolution tree-based approach. Scientific Reports, 8 (1), 538. doi:10.1038/s41598-017-18993-5

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (May 2017). Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis. Radiotherapy and Oncology, 123 (Supplement 1), 545. doi:10.1016/S0167-8140(17)31424-X

Berkovic, P., GULYBAN, A., Nguyen, P. V., DECHAMBRE, D., Martinive, P., JANSEN, N., Lakosi, F., Janvary, L., & Coucke, P. (20 March 2017). Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence. Clinical Colorectal Cancer, 16 (4), 349-357.e1. doi:10.1016/j.clcc.2017.03.006

VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 2eme partie : l'interet des approches multimodales avec ou sans chirurgie. Revue Médicale de Liège, 72 (4), 168-174.

VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 1ere partie : le point sur les approches chirurgicales et non chirurgicales. Revue Médicale de Liège, 72 (2), 58-63.

Vandaele, R., LALLEMAND, F., MARTINIVE, P., GULYBAN, A., JODOGNE, S., COUCKE, P., Geurts, P., & Marée, R. (2017). Automated multimodal volume registration based on supervised 3D anatomical landmark detection. In SCITEPRESS Digital Library.

Leroi, N., LALLEMAND, F., COUCKE, P., Noël, A., & MARTINIVE, P. (30 March 2016). Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Frontiers in Pharmacology, 7, 1-9. doi:10.3389/fphar.2016.00078

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (2016). Diffusion MRI for following tumor modifications after neoadjuvant radiotherapy. Radiotherapy and Oncology, 119, 966-S967.

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (April 2015). Functional MRI for predicting metastatic spreading at the time of surgery after neoadjuvant radiotherapy. Radiotherapy and Oncology, 115 (Supplement 1), 832-S833. doi:10.1016/S0167-8140(15)41518-X

Vandaele, R., Marée, R., COUCKE, P., GULYBAN, A., LALLEMAND, F., Geurts, P., JODOGNE, S., & MARTINIVE, P. (April 2015). Automated Landmark Detection For Rigid Registration Between The Simulation-CT and the Treatment CBCT [Poster presentation]. 3rd ESTRO FORUM, Barcelone, Spain.

Goffart, N., KROONEN, J., Di Valentin, E., Dedobbeleer, M., Denne, A., Martinive, P., & Rogister, B. (2015). Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling. Neuro-Oncology, 17 (1), 81-94. doi:10.1093/neuonc/nou144

Leroi, N., Sounni, N. E., Van Overmeire, E., Blacher, S., Marée, R., Van Ginderachter, J., Lallemand, F., LENAERTS, E., COUCKE, P., Noël, A.* , & MARTINIVE, P.*. (2015). The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model. Oncotarget. doi:10.18632/oncotarget.5931
* These authors have contributed equally to this work.

Leroi, N., Blacher, S., Marée, R., Noël, A., COUCKE, P., & MARTINIVE, P. (29 June 2014). Does neoadjuvant radiotherapy and the timing of surgery modify metastatic dissemination? [Paper presentation]. 15th International Biennial Congress of the Metastasis Research Society, Heidelberg, Germany.

COUCKE, P., & MARTINIVE, P. (2014). LA RADIOBIOLOGIE POUR LES NÉOPHYTES. Revue Médicale de Liège, 69 (Supp 1), 16-19.

LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28.

MARTINIVE, P., ALLEPAERTS, S., VAN DAELE, D., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., COLLIGNON, J., LENNERTS, E., VANDERICK, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM CHEZ LA PERSONNE ÂGÉE: Quel bénéfice pour le traitement ? Revue Médicale de Liège, 69 (Supp 1), 47-52.

MARTINIVE, P., VAN DAELE, D., LENNERTS, E., ALLEPAERTS, S., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., VANDERICK, J., COLLIGNON, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM : quand, comment et pourquoi ? Revue Médicale de Liège, 69 (Supp 1), 37-46.

JODOGNE, S., SOBCZAK, S., DEVILLERS, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (April 2013). Orthanc - Lightweight, Scriptable DICOM Server for Medical Image Management in Radiotherapy. Radiotherapy and Oncology, 106 (2), 488.

Leroi, N., NOEL, A., COUCKE, P., & MARTINIVE, P. (2013). Optimizing the timing of surgery after neoadjuvant radiotherapy for decreasing tumor metastasis [Paper presentation]. BACR, Anvers, Belgium.

Leroi, N., Noël, A., COUCKE, P., & MARTINIVE, P. (May 2012). Modeling neoadjuvant radiotherapy for improving treatments efficacy [Poster presentation]. ESTRO 31.

Leroi, N., COUCKE, P., Noël, A., & MARTINIVE, P. (February 2012). Tailoring the timing of surgery based on the neoadjuvant radiotherapy schedule for decreasing tumor dissemination at the time of surgical procedure [Paper presentation]. International Conference on Transnational Research in Radiation Oncology, Genève, Switzerland.

JANVARY, Z. L., JANSEN, N., MARTINIVE, P., & COUCKE, P. (2011). New indications for radiotherapy: primary liver cancer and secondary liver oligometastases. Belgian Journal of Medical Oncology, 5 (1), 8-13.

Leroi, N., boujouf, S., COUCKE, P., Noël, A., & MARTINIVE, P. (January 2011). does neoadjuvant radiotherapy promote tumor dissemination [Poster presentation]. BACR-ABEC-BVSK.

WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine.

JANVARY, Z. L., Broens, A., MARTINIVE, P., Vvavassis, P., Fieuw, J., LENAERTS, E., & COUCKE, P. (September 2010). 4DCT EVALUATION OF THE RESPIRATORY-RELATED MOVEMENT OF THE BREAST USING SURGICAL CLIPS AS FIDUCIALS [Poster presentation]. ESTRO.

JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM. Radiotherapy and Oncology, 96 (supp 1).

Daneau, G., Boidot, R., MARTINIVE, P., & Feron, O. (15 January 2010). Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases. Clinical Cancer Research, 16 (2), 410-419. doi:10.1158/1078-0432.CCR-09-0583

MARTINIVE, P., & COUCKE, P. (2010). La vascularisation tumorale en tant que source de résistance aux traitements de radiothérapie et chimiothérapie. Revue Médicale de Liège, 65 (3), 133-139.

Martinive, P. (2008). Impact of cyclic hypoxia on HIF-1a regulation in endothelial cells: new insights for anti-tumor treatments. FEBS Journal. doi:10.1111/j.1742-4658.2008.06798.x

Cron, G. O., Ansiaux, MARTINIVE, P., Feron, O., Gallez, B., & Beghein, N. (Other coll.). (2008). (19) F NMR in vivo spectroscopy reflects the effectiveness of perfusion - enhancing vascular modifiers for improving gemcitabine chemotheraypy. Magnetic Resonance in Medicine. doi:10.1002/mrm.21469

Crokart, N., JORDAN, B., BAUDELET, C., CRON, G., HOTTON, J., RADERMACHER, K., GREGOIRE, V., BEGHIN, N., MARTINIVE, P., BOUZIN, C., FERON, O., & GALLEZ, B. (2007). Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen Consumption. Clinical Cancer Research, 15 (13), 630/5. doi:10.1158/1078-0432.CCR-06-0802

Martinive, P. (January 2007). Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anti-cancer therapies [Poster presentation]. Meeting Gand, Gand, Belgium.

Martinive, P., DEFRESNE, F., BOUZIN, C., SALIEZ, J., LAIR, F., GREGOIRE, V., MICHIELS, C., DESSY, C., & FERON, O. (15 December 2006). Preconditioning of the Tumor Vasculature and Tumor Cells by Intermittent Hypoxia: Implications for Anticancer Therapies. Cancer Research, 66 (24), 11736-44. doi:10.1158/0008-5472.CAN-06-2056

SEGERS, J., DI FAZIO, V., ANSIAUX, R., MARTINIVE, P., FERON, O., Wallemacq, P., & GALLEZ, B. (28 November 2006). Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the ‘normalization’ window of the tumor vasculature. Cancer Letters, 244 (1), 129/35. doi:10.1016/j.canlet.2005.12.017

ANSIAUX, R., BAUDELET, C., JORDAN, B., CROKART, N., DEWEVER, J., MARTINIVE, P., GREGOIRE, V., FERON, O., & GALLEZ. (01 October 2006). Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. Cancer Research, 66 (19), 9698/704. doi:10.1158/0008-5472.CAN-06-1854

Martinive, P., DE WEVER, J., BOUZIN, C., BAUDELET, C., ONVEAUX, P., GREGOIRE, V., & FERON, O. (June 2006). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery. Molecular Cancer Therapeutics, 5 (6), 1620/7. doi:10.1158/1535-7163.MCT-05-0472

SBAA, E., DE WEVER, J., MARTINIVE, P., BOUZIN, C., FRERART, F., BALLIGAND, J.-L., DESSY, C., & FERON, O. (12 May 2006). Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circulation Research, 98 (9), 1219/27. doi:10.1161/01.RES.0000220648.80170.8b

Ansiaux, R., Baudelet, C., Cron, MARTINIVE, P., DEWEVER, J., GREGOIRE, V., FERON, O., & Gallez. (May 2006). Evolution of the tumor oxygenation and perfusion at the early stage of the treatment with SU5416, an inhibitor of Flk-1 tyrosine kinase [Poster presentation]. Proc. Intl. Soc. Mag. Reson. Med.

Martinive, P. (2006). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable parameter to improve drug delivrery [Paper presentation]. Meeting Brussels, Bruxelles, Belgium.

ANSIAUX, R., BAUDELET, C., CRON, G., SEGERS, J., DESSY, C., Martinive, P., DE WEVER, J., VERRAX, J., WAUTHIER, V., BEGHEIN, N., GREGOIRE, V., BUC CALDERON, P., FERON, O., & GALLEZ, B. (15 February 2006). Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clinical Cancer Research, 12 (4), 1276/83. doi:10.1158/1078-0432.CCR-05-1222

Brouet, A., DeWever, J., MARTINIVE, P., Havaux, X., Bouzin, C., Sonveaux, P., Feron, O., & Martinive, P. (Other coll.). (2005). Anti-tumor effect of caveolin gene delivery are mediated through the inhibition of the pro-angiogenic and vasodilatating effect of nitric oxide. FASEB Journal, 602-4.

ANSIAUX, R., BAUDELET, C., JORDAN, B., BEGHEIN, N., SONVEAUX, P., DE WEVER, J., MARTINIVE, P., GREGOIRE, V., FERON, O., & Gallez, B. (15 January 2005). Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clinical Cancer Research, 15 (11), 743-750.

Crokart, Jordan, Baudelet, C., Cron, Hotton, Radermacher, GREGOIRE, V., Beghein, MARTINIVE, P., FERON, O., & Gallez. (26 November 2004). Characterization of the tumor micro-environment after administration of glucocorticoids to understand their radiosensitization effect [Poster presentation]. 3rd one day symposium.

Martinive, P., Sonveaux, P., Brouet, A., & Feron, O. (September 2004). Intrinsic and irradiation-induced tumor selectivity of liposome-based gene therapy targeting Akt activation [Poster presentation]. Experimental and Molecular Therapeutics.

Martinive, P., Sonveaux, P., DeWever, J., Batova, Z., Daneau, G., Pelat, M., Ghisdal, P., Grégoire, V., Dessy, C., Balligand, J.-L., & Feron, O. (2004). caveolin-1 expression is critical for VEGF-induced inschemic hindlimb collateralization and NO-mediated angiogenisis. Circulation Research, (95 (2)), 154-61.

Sonveaux, P., Dessy, MARTINIVE, P., Havaux, X., Jordan, B., Gallez, B., Gregoire, V., Balligand, J.-L., & Feron, O. (May 2004). Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Research, 1 (64), 3209-14. doi:10.1158/0008-5472.CAN-03-1291